Which laboratory tests should be ordered to diagnose gonorrhea, Trichomonas vaginalis, and chlamydia?

Laboratory Testing for Gonorrhea, Chlamydia, and Trichomonas

Order nucleic acid amplification tests (NAATs) for all three infections simultaneously using a single specimen—either a vaginal swab (self-collected or clinician-collected for women), first-void urine, or urethral swab (for men)—as NAATs offer superior sensitivity and specificity compared to older methods and are FDA-cleared for detecting N. gonorrhoeae, C. trachomatis, and T. vaginalis. 1, 2

Recommended Testing Approach

Specimen Collection Options

For Women:

• Vaginal swabs (self-collected or clinician-collected) - preferred specimen type
• Endocervical swabs (clinician-collected)
• First-void urine
• NAATs are FDA-cleared for all these specimen types 1

For Men:

• First-void urine - preferred for ease of collection
• Urethral swabs
• Both specimen types perform well with NAATs 1, 2

Test Selection

NAATs are the gold standard for detecting all three pathogens because they provide:

• Sensitivity >90-95% for gonorrhea and chlamydia 1, 3
• Specificity >98-99% 1, 3
• Ability to test multiple pathogens from a single specimen 4, 5
• Superior performance compared to culture or wet mount microscopy 6, 7

Modern multiplex NAATs can simultaneously detect N. gonorrhoeae, C. trachomatis, and T. vaginalis from the same specimen, making testing efficient and comprehensive 4, 8, 5.

Important Testing Considerations

When Culture is Still Needed

Reserve culture for specific situations:

• Extragenital sites (rectum, pharynx) where NAATs are not FDA-cleared, though some laboratories have validated NAATs for these sites 1
• Persistent infection after treatment to obtain antimicrobial susceptibility testing 1
• Medicolegal cases where culture confirmation may be required

What NOT to Use

Avoid these outdated methods:

• Gram stain alone for women (insufficient sensitivity) 1
• Wet mount microscopy for T. vaginalis (sensitivity only 50-70% compared to NAAT) 6, 7
• Gram stain for pharyngeal or rectal specimens (not reliable) 1

Concurrent Testing Requirements

All patients tested for gonorrhea should also be tested for:

• Chlamydia (co-infection rate is high) 1
• Syphilis 1
• HIV 1

This is critical because N. gonorrhoeae and C. trachomatis frequently co-exist, and identifying one infection should prompt testing for others 1.

Clinical Pearls and Pitfalls

Common Pitfalls to Avoid

1. Don't rely on symptoms alone: Most infections are asymptomatic, particularly in women 1, 9

2. Don't skip T. vaginalis testing: While historically undertested, T. vaginalis is the most common non-viral STI and should be included in routine screening 7, 10

3. Don't use non-NAAT tests for chlamydia: NAATs have significantly higher sensitivity than older methods 2

4. Don't postpone testing due to discharge or menses: Testing can proceed after removing excess discharge with a saline-soaked swab 11

Self-Collection Advantages

Self-collected vaginal swabs demonstrate:

• Comparable accuracy to clinician-collected specimens 4, 3
• High patient acceptability 6
• Potential to increase screening access 3
• Cost-effectiveness 6, 7

Recent FDA authorization of self-collection kits for non-clinical settings represents a major advancement in STI testing accessibility 3.

Specimen Handling

• Dry swabs can be used and perform comparably to swabs in transport medium for PCR testing 5
• Specimens should be processed according to manufacturer specifications
• Most NAATs are stable at room temperature for several hours 5

Cost-Effectiveness

Using NAATs for symptomatic women costs approximately £260 per positive case diagnosed compared to £716 using traditional microbiological methods 7. The superior sensitivity and ability to test multiple pathogens simultaneously makes NAATs the most cost-effective approach 6, 7.